Literature DB >> 33720292

Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.

Brian J Boyarsky1, William A Werbel2, Robin K Avery2, Aaron A R Tobian3, Allan B Massie1, Dorry L Segev1, Jacqueline M Garonzik-Wang1.   

Abstract

Entities:  

Year:  2021        PMID: 33720292      PMCID: PMC7961463          DOI: 10.1001/jama.2021.4385

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  200 in total

1. 

Authors:  Borja Quiroga; Andrés Fernández Ramos; Alicia Delgado Arroyo
Journal:  Nefrologia (Engl Ed)       Date:  2021-05-01

2.  Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses.

Authors:  Ilies Benotmane; Gabriela Gautier; Peggy Perrin; Jérôme Olagne; Noëlle Cognard; Samira Fafi-Kremer; Sophie Caillard
Journal:  JAMA       Date:  2021-07-23       Impact factor: 56.272

Review 3.  Immunizations in Chronic Kidney Disease and Kidney Transplantation.

Authors:  Tara M Babu; Camille N Kotton
Journal:  Curr Treat Options Infect Dis       Date:  2021-05-17

4.  Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy.

Authors:  Dan Cohen; Shir Hazut Krauthammer; Yael C Cohen; Chava Perry; Irit Avivi; Yair Herishanu; Einat Even-Sapir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-05-08       Impact factor: 9.236

5.  Antibody Response to COVID-19 vaccination in Patients Receiving Dialysis.

Authors:  Shuchi Anand; Maria E Montez-Rath; Jialin Han; Pablo Garcia; LinaCel Cadden; Patti Hunsader; Russell Kerschmann; Paul Beyer; Mary Dittrich; Geoffrey A Block; Scott D Boyd; Julie Parsonnet; Glenn M Chertow
Journal:  medRxiv       Date:  2021-05-12

6.  [Vaccination against SARS-CoV-2 in cancer patients].

Authors:  Marie von Lilienfeld-Toal; Christina Rieger; Nicola Giesen; Bernhard Wörmann
Journal:  Onkologe (Berl)       Date:  2021-05-17       Impact factor: 0.234

7.  SARS-CoV-2 ferritin nanoparticle vaccines elicit broad SARS coronavirus immunogenicity.

Authors:  M Gordon Joyce; Wei-Hung Chen; Rajeshwer S Sankhala; Agnes Hajduczki; Paul V Thomas; Misook Choe; William Chang; Caroline E Peterson; Elizabeth Martinez; Elaine B Morrison; Clayton Smith; Aslaa Ahmed; Lindsay Wieczorek; Alexander Anderson; Rita E Chen; James Brett Case; Yifan Li; Therese Oertel; Lorean Rosado; Akshaya Ganesh; Connor Whalen; Joshua M Carmen; Letzibeth Mendez-Rivera; Christopher Karch; Neelakshi Gohain; Zuzana Villar; David McCurdy; Zoltan Beck; Jiae Kim; Shikha Shrivastava; Ousman Jobe; Vincent Dussupt; Sebastian Molnar; Ursula Tran; Chandrika B Kannadka; Michelle Zemil; Htet Khanh; Weimin Wu; Matthew A Cole; Debra K Duso; Larry W Kummer; Tricia J Lang; Shania E Muncil; Jeffrey R Currier; Shelly J Krebs; Victoria R Polonis; Saravanan Rajan; Patrick M McTamney; Mark T Esser; William W Reiley; Morgane Rolland; Natalia de Val; Michael S Diamond; Gregory D Gromowski; Gary R Matyas; Mangala Rao; Nelson L Michael; Kayvon Modjarrad
Journal:  bioRxiv       Date:  2021-05-10

8.  Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipient.

Authors:  Jon Klein; Anderson Brito; Paul Trubin; Peiwen Lu; Patrick Wong; Tara Alpert; Mario Pena-Hernandez; Winston Haynes; Kathy Kamath; Feimei Liu; Chantal Vogels; Joseph Fauver; Carolina Lucas; Ji Eun Oh; Tianyang Mao; Julio Silva; Anne Wyllie; M Catherine Muenker; Arnau Casanovas-Massana; Adam Moore; Mary Petrone; Chaney Kalinich; Charles Dela Cruz; Shelli Farhadian; Aaron Ring; John Shon; Albert Ko; Nathan Grubaugh; Benjamin Goldman-Israelow; Akiko Iwasaki; Marwan Azar
Journal:  Res Sq       Date:  2021-05-05

9.  Improving the Outcomes of Immunocompromised Patients With Coronavirus Disease 2019.

Authors:  Ghady Haidar; John W Mellors
Journal:  Clin Infect Dis       Date:  2021-09-15       Impact factor: 9.079

10.  Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly.

Authors:  Emire Seyahi; Guldaran Bakhdiyarli; Mert Oztas; Mert Ahmet Kuskucu; Yesim Tok; Necdet Sut; Guzin Ozcifci; Ali Ozcaglayan; Ilker Inanc Balkan; Nese Saltoglu; Fehmi Tabak; Vedat Hamuryudan
Journal:  Rheumatol Int       Date:  2021-06-09       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.